{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:59:38Z","timestamp":1792634378097,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Histopathological analysis stands as the gold standard for the identification and differentiation of inflammatory neuromuscular diseases. These disorders continue to constitute a diagnostic challenge due to their clinical heterogeneity, rarity and overlapping features. To establish standardized protocols for the diagnosis of inflammatory neuromuscular diseases, the development of cost-effective and widely applicable tools is crucial, especially in settings constrained by limited resources. The focus of this review is to emphasize the diagnostic value of major histocompatibility complex (MHC) and complement patterns in the immunohistochemical analysis of these diseases. We explore the immunological background of MHC and complement signatures that characterize inflammatory features, with a specific focus on idiopathic inflammatory myopathies. With this approach, we aim to provide a diagnostic algorithm that may improve and simplify the diagnostic workup based on a limited panel of stainings. Our approach acknowledges the current limitations in the field of inflammatory neuromuscular diseases, particularly the scarcity of large-scale, prospective studies that validate the diagnostic potential of these markers. Further efforts are needed to establish a consensus on the diagnostic protocol to effectively distinguish these diseases.<\/jats:p>","DOI":"10.1007\/s00401-023-02669-8","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:02:03Z","timestamp":1705017723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases"],"prefix":"10.1007","volume":"147","author":[{"given":"Christopher","family":"Nelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Kleefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina B.","family":"Schroeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Hilmar","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Preu\u00dfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-2103","authenticated-orcid":false,"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"2669_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102586","volume":"19","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Anquetil C, Manouchehri A, Benveniste O, Lambotte O, Lebrun-Vignes B et al (2020) Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities. Autoimmun Rev 19:102586. https:\/\/doi.org\/10.1016\/j.autrev.2020.102586","journal-title":"Autoimmun Rev"},{"key":"2669_CR2","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","volume":"90","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N et al (2018) Necrosis in anti-SRP+ and anti-HMGCR+myopathies: role of autoantibodies and complement. Neurology 90:e507\u2013e517. https:\/\/doi.org\/10.1212\/WNL.0000000000004923","journal-title":"Neurology"},{"key":"2669_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","volume":"16","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O (2020) Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol 16:689\u2013701. https:\/\/doi.org\/10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"2669_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ajpath.2015.11.010","volume":"186","author":"Y Allenbach","year":"2016","unstructured":"Allenbach Y, Leroux G, Su\u00e1rez-Calvet X, Preusse C, Gallardo E, Hervier B et al (2016) Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression. Am J Pathol 186:691\u2013700. https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.010","journal-title":"Am J Pathol"},{"key":"2669_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working Group (2018) 224th ENMC international workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord 28:87\u201399. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"key":"2669_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40478-014-0154-2","volume":"2","author":"J Aouizerate","year":"2014","unstructured":"Aouizerate J, De Antonio M, Bassez G, Gherardi RK, Berenbaum F, Guillevin L et al (2014) Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol Commun 2:154. https:\/\/doi.org\/10.1186\/s40478-014-0154-2","journal-title":"Acta Neuropathol Commun"},{"key":"2669_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0140-6736(85)91384-4","volume":"1","author":"ST Appleyard","year":"1985","unstructured":"Appleyard ST, Dunn MJ, Dubowitz V, Rose ML (1985) Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet 1:361\u2013363. https:\/\/doi.org\/10.1016\/s0140-6736(85)91384-4","journal-title":"Lancet"},{"key":"2669_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.410230210","volume":"23","author":"K Arahata","year":"1988","unstructured":"Arahata K, Engel AG (1988) Monoclonal antibody analysis of mononuclear cells in myopathies. IV: cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 23:168\u2013173. https:\/\/doi.org\/10.1002\/ana.410230210","journal-title":"Ann Neurol"},{"key":"2669_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-022-01320-z","volume":"10","author":"N Becker","year":"2022","unstructured":"Becker N, Moore SA, Jones KA (2022) The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies. Acta Neuropathol Commun 10:17. https:\/\/doi.org\/10.1186\/s40478-022-01320-z","journal-title":"Acta Neuropathol Commun"},{"key":"2669_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fneur.2019.00554","volume":"10","author":"O Benveniste","year":"2019","unstructured":"Benveniste O, Goebel H-H, Stenzel W (2019) Biomarkers in inflammatory myopathies\u2014an expanded definition. Front Neurol 10:554. https:\/\/doi.org\/10.3389\/fneur.2019.00554","journal-title":"Front Neurol"},{"key":"2669_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","volume":"29","author":"O Benveniste","year":"2016","unstructured":"Benveniste O, Stenzel W, Allenbach Y (2016) Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol 29:662\u2013673. https:\/\/doi.org\/10.1097\/WCO.0000000000000376","journal-title":"Curr Opin Neurol"},{"key":"2669_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","volume":"129","author":"O Benveniste","year":"2015","unstructured":"Benveniste O, Stenzel W, Hilton-Jones D, Sandri M, Boyer O, van Engelen BGM (2015) Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathol 129:611\u2013624. https:\/\/doi.org\/10.1007\/s00401-015-1384-5","journal-title":"Acta Neuropathol"},{"key":"2669_CR13","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0961203320918021","volume":"29","author":"N Bitencourt","year":"2020","unstructured":"Bitencourt N, Solow EB, Wright T, Bermas BL (2020) Inflammatory myositis in systemic lupus erythematosus. Lupus 29:776\u2013781. https:\/\/doi.org\/10.1177\/0961203320918021","journal-title":"Lupus"},{"key":"2669_CR14","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.gendis.2022.01.001","volume":"9","author":"J Christiansen","year":"2022","unstructured":"Christiansen J, G\u00fcttsches A-K, Schara-Schmidt U, Vorgerd M, Heute C, Preusse C et al (2022) ANO5-related muscle diseases: from clinics and genetics to pathology and research strategies. Genes Dis 9:1506\u20131520. https:\/\/doi.org\/10.1016\/j.gendis.2022.01.001","journal-title":"Genes Dis"},{"key":"2669_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/s0165-5728(03)00255-8","volume":"142","author":"P Confalonieri","year":"2003","unstructured":"Confalonieri P, Oliva L, Andreetta F, Lorenzoni R, Dassi P, Mariani E et al (2003) Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol 142:130\u2013136. https:\/\/doi.org\/10.1016\/s0165-5728(03)00255-8","journal-title":"J Neuroimmunol"},{"key":"2669_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/1744666X.2023.2212162","volume":"19","author":"CM Connolly","year":"2023","unstructured":"Connolly CM, Paik JJ (2023) Clinical pearls and promising therapies in myositis. Expert Rev Clin Immunol 19:797\u2013811. https:\/\/doi.org\/10.1080\/1744666X.2023.2212162","journal-title":"Expert Rev Clin Immunol"},{"key":"2669_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11940-020-00632-6","volume":"22","author":"E Cort\u00e9s-Vicente","year":"2020","unstructured":"Cort\u00e9s-Vicente E, Gallardo E, \u00c1lvarez-Velasco R, Illa I (2020) Myasthenia gravis treatment updates. Curr Treat Options Neurol 22:24. https:\/\/doi.org\/10.1007\/s11940-020-00632-6","journal-title":"Curr Treat Options Neurol"},{"key":"2669_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/mus.24197","volume":"50","author":"CD Crockett","year":"2014","unstructured":"Crockett CD, Ruggieri A, Gujrati M, Zallek CM, Ramachandran N, Minassian BA et al (2014) Late adult-onset of X-linked myopathy with excessive autophagy. Muscle Nerve 50:138\u2013144. https:\/\/doi.org\/10.1002\/mus.24197","journal-title":"Muscle Nerve"},{"key":"2669_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/1744666X.2022.2054803","volume":"18","author":"MC Dalakas","year":"2022","unstructured":"Dalakas MC (2022) Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits. Expert Rev Clin Immunol 18:413\u2013423. https:\/\/doi.org\/10.1080\/1744666X.2022.2054803","journal-title":"Expert Rev Clin Immunol"},{"key":"2669_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/PAI.0b013e31827d7f16","volume":"21","author":"L Das","year":"2013","unstructured":"Das L, Blumbergs PC, Manavis J, Limaye VS (2013) Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy. Appl Immunohistochem Mol Morphol 21:539\u2013542. https:\/\/doi.org\/10.1097\/PAI.0b013e31827d7f16","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2669_CR21","doi-asserted-by":"publisher","first-page":"5069042","DOI":"10.1155\/2018\/5069042","volume":"2018","author":"LV De Camargo","year":"2018","unstructured":"de De CamargoCarvalho LVMS, Shinjo SK, de Oliveira ASB, Zanoteli E (2018) Clinical, histological, and immunohistochemical findings in inclusion body myositis. Biomed Res Int 2018:5069042. https:\/\/doi.org\/10.1155\/2018\/5069042","journal-title":"Biomed Res Int"},{"key":"2669_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead154","author":"J Demortier","year":"2023","unstructured":"Demortier J, Vautier M, Chosidow O, Gallay L, Bessis D, Berezne A et al (2023) Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/kead154","journal-title":"Rheumatology (Oxford)"},{"key":"2669_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00401-015-1393-4","volume":"129","author":"JJ Dowling","year":"2015","unstructured":"Dowling JJ, Moore SA, Kalimo H, Minassian BA (2015) X-linked myopathy with excessive autophagy: a failure of self-eating. Acta Neuropathol 129:383\u2013390. https:\/\/doi.org\/10.1007\/s00401-015-1393-4","journal-title":"Acta Neuropathol"},{"key":"2669_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/jir.2011.0045","volume":"31","author":"KB Elkon","year":"2011","unstructured":"Elkon KB, Stone VV (2011) Type I interferon and systemic lupus erythematosus. J Interferon Cytokine Res 31:803\u2013812. https:\/\/doi.org\/10.1089\/jir.2011.0045","journal-title":"J Interferon Cytokine Res"},{"key":"2669_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12840","volume":"48","author":"B Ellezam","year":"2022","unstructured":"Ellezam B, Leclair V, Troyanov Y, Bersali I, Giannini M, Hoa S et al (2022) Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis. Neuropathol Appl Neurobiol 48:e12840. https:\/\/doi.org\/10.1111\/nan.12840","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2669_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-021-02335-x","volume":"142","author":"B Ellezam","year":"2021","unstructured":"Ellezam B, Leclair V, Troyanov Y, Meyer A, Hudson M, Landon-Cardinal O (2021) Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of \u201cscleromyositis.\u201d Acta Neuropathol 142:395\u2013397. https:\/\/doi.org\/10.1007\/s00401-021-02335-x","journal-title":"Acta Neuropathol"},{"key":"2669_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1749-6632.1987.tb51301.x","volume":"505","author":"AG Engel","year":"1987","unstructured":"Engel AG, Arahata K (1987) The membrane attack complex of complement at the endplate in myasthenia gravis. Ann N Y Acad Sci 505:326\u2013332. https:\/\/doi.org\/10.1111\/j.1749-6632.1987.tb51301.x","journal-title":"Ann N Y Acad Sci"},{"key":"2669_CR28","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1097\/RHU.0000000000001736","volume":"28","author":"M Essouma","year":"2022","unstructured":"Essouma M, Noubiap JJ, Singwe-Ngandeu M, Hachulla E (2022) Epidemiology of idiopathic inflammatory myopathies in Africa: a contemporary systematic review. J Clin Rheumatol 28:e552\u2013e562. https:\/\/doi.org\/10.1097\/RHU.0000000000001736","journal-title":"J Clin Rheumatol"},{"key":"2669_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/bpa.12772","volume":"30","author":"N Fischer","year":"2020","unstructured":"Fischer N, Preu\u00dfe C, Radke J, Pehl D, Allenbach Y, Schneider U et al (2020) Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies. Brain Pathol 30:261\u2013271. https:\/\/doi.org\/10.1111\/bpa.12772","journal-title":"Brain Pathol"},{"key":"2669_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.974078","volume":"13","author":"M Giannini","year":"2023","unstructured":"Giannini M, Ellezam B, Leclair V, Lefebvre F, Troyanov Y, Hudson M et al (2023) Scleromyositis: a distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis. Front Immunol 13:974078. https:\/\/doi.org\/10.3389\/fimmu.2022.974078","journal-title":"Front Immunol"},{"key":"2669_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4049\/jimmunol.149.2.661","volume":"149","author":"N Goebels","year":"1992","unstructured":"Goebels N, Michaelis D, Wekerle H, Hohlfeld R (1992) Human myoblasts as antigen-presenting cells. J Immunol 149:661\u2013667. https:\/\/doi.org\/10.4049\/jimmunol.149.2.661","journal-title":"J Immunol"},{"key":"2669_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA (2010) Dermatomyositis and type 1 interferons. Curr Rheumatol Rep 12:198\u2013203. https:\/\/doi.org\/10.1007\/s11926-010-0101-6","journal-title":"Curr Rheumatol Rep"},{"key":"2669_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","volume":"15","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA (2019) Inclusion body myositis: clinical features and pathogenesis. Nat Rev Rheumatol 15:257\u2013272. https:\/\/doi.org\/10.1038\/s41584-019-0186-x","journal-title":"Nat Rev Rheumatol"},{"key":"2669_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","volume":"87","author":"A Hida","year":"2016","unstructured":"Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M et al (2016) Anti-TIF1-\u03b3 antibody and cancer-associated myositis: a clinicohistopathologic study. Neurology 87:299\u2013308. https:\/\/doi.org\/10.1212\/WNL.0000000000002863","journal-title":"Neurology"},{"key":"2669_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00401-020-02147-5","volume":"139","author":"S Hoffmann","year":"2020","unstructured":"Hoffmann S, Harms L, Schuelke M, R\u00fcckert J-C, Goebel H-H, Stenzel W et al (2020) Complement deposition at the neuromuscular junction in seronegative myasthenia gravis. Acta Neuropathol 139:1119\u20131122. https:\/\/doi.org\/10.1007\/s00401-020-02147-5","journal-title":"Acta Neuropathol"},{"key":"2669_CR36","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","volume":"16","author":"JF Howard","year":"2017","unstructured":"Howard JF, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I et al (2017) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 16:976\u2013986. https:\/\/doi.org\/10.1016\/S1474-4422(17)30369-1","journal-title":"Lancet Neurol"},{"key":"2669_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/nan.12730","volume":"47","author":"H K\u00f6lbel","year":"2021","unstructured":"K\u00f6lbel H, Preu\u00dfe C, Brand L, von Moers A, Della Marina A, Schuelke M et al (2021) Inflammation, fibrosis and skeletal muscle regeneration in LGMDR9 are orchestrated by macrophages. Neuropathol Appl Neurobiol 47:856\u2013866. https:\/\/doi.org\/10.1111\/nan.12730","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2669_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nmd.2011.04.010","volume":"21","author":"H Komaki","year":"2011","unstructured":"Komaki H, Hayashi YK, Tsuburaya R, Sugie K, Kato M, Nagai T et al (2011) Inflammatory changes in infantile-onset LMNA-associated myopathy. Neuromuscul Disord 21:563\u2013568. https:\/\/doi.org\/10.1016\/j.nmd.2011.04.010","journal-title":"Neuromuscul Disord"},{"key":"2669_CR39","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/cells8101270","volume":"8","author":"JK Kulski","year":"2019","unstructured":"Kulski JK, Shiina T, Dijkstra JM (2019) Genomic diversity of the major histocompatibility complex in health and disease. Cells 8:1270. https:\/\/doi.org\/10.3390\/cells8101270","journal-title":"Cells"},{"key":"2669_CR40","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/brain\/aww122","volume":"139","author":"R Lahoria","year":"2016","unstructured":"Lahoria R, Selcen D, Engel AG (2016) Microvascular alterations and the role of complement in dermatomyositis. Brain 139:1891\u20131903. https:\/\/doi.org\/10.1093\/brain\/aww122","journal-title":"Brain"},{"key":"2669_CR41","doi-asserted-by":"publisher","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","volume":"90","author":"R De Lorenzo","year":"2018","unstructured":"De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C et al (2018) Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies. Neurology 90:e2068\u2013e2076. https:\/\/doi.org\/10.1212\/WNL.0000000000005638","journal-title":"Neurology"},{"key":"2669_CR42","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"2669_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14:269\u2013278. https:\/\/doi.org\/10.1038\/nrrheum.2018.41","journal-title":"Nat Rev Rheumatol"},{"key":"2669_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/bpa.12864","volume":"30","author":"D Mair","year":"2020","unstructured":"Mair D, Biskup S, Kress W, Abicht A, Br\u00fcck W, Zechel S et al (2020) Differential diagnosis of vacuolar myopathies in the NGS era. Brain Pathol 30:877\u2013896. https:\/\/doi.org\/10.1111\/bpa.12864","journal-title":"Brain Pathol"},{"key":"2669_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W, Benveniste O, ENMC 239th Workshop Study Group (2020) 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018. Neuromuscul Disord 30:70\u201392. https:\/\/doi.org\/10.1016\/j.nmd.2019.10.005","journal-title":"Neuromuscul Disord"},{"key":"2669_CR46","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/s2665-9913(23)00003-6","volume":"5","author":"AL Mammen","year":"2023","unstructured":"Mammen AL, Amato AA, Dimachkie MM, Chinoy H, Hussain Y, Lilleker JB et al (2023) Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. Lancet Rheumatol 5:e67\u2013e76. https:\/\/doi.org\/10.1016\/s2665-9913(23)00003-6","journal-title":"Lancet Rheumatol"},{"key":"2669_CR47","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","volume":"363","author":"JR Mendell","year":"2010","unstructured":"Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S et al (2010) Dystrophin immunity in Duchenne\u2019s muscular dystrophy. N Engl J Med 363:1429\u20131437. https:\/\/doi.org\/10.1056\/NEJMoa1000228","journal-title":"N Engl J Med"},{"key":"2669_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer A, Meyer N, Schaeffer M, Gottenberg J-E, Geny B, Sibilia J (2015) Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 54:50\u201363. https:\/\/doi.org\/10.1093\/rheumatology\/keu289","journal-title":"Rheumatology"},{"key":"2669_CR49","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/art.38137","volume":"65","author":"FW Miller","year":"2013","unstructured":"Miller FW, Cooper RG, Vencovsk\u00fd J, Rider LG, Danko K, Wedderburn LR et al (2013) Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum 65:3239\u20133247. https:\/\/doi.org\/10.1002\/art.38137","journal-title":"Arthritis Rheum"},{"key":"2669_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ana.24255","volume":"76","author":"TJ M\u00fcller","year":"2014","unstructured":"M\u00fcller TJ, Kraya T, Stoltenburg-Didinger G, Hanisch F, Kornhuber M, Stoevesandt D et al (2014) Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 76:669\u2013680. https:\/\/doi.org\/10.1002\/ana.24255","journal-title":"Ann Neurol"},{"key":"2669_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.26447","volume":"60","author":"S Muppidi","year":"2019","unstructured":"Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I et al (2019) Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. Muscle Nerve 60:14\u201324. https:\/\/doi.org\/10.1002\/mus.26447","journal-title":"Muscle Nerve"},{"key":"2669_CR52","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E et al (2000) Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 97:9209\u20139214","journal-title":"Proc Natl Acad Sci USA"},{"key":"2669_CR53","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/nan.12690","volume":"47","author":"F Napolitano","year":"2021","unstructured":"Napolitano F, Terracciano C, Bruno G, De Blasiis P, Lombardi L, Gialluisi A et al (2021) Novel autophagic vacuolar myopathies: phenotype and genotype features. Neuropathol Appl Neurobiol 47:664\u2013678. https:\/\/doi.org\/10.1111\/nan.12690","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2669_CR54","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma MLM, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823\u2013836. https:\/\/doi.org\/10.1038\/nri3084","journal-title":"Nat Rev Immunol"},{"key":"2669_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40478-022-01389-6","volume":"10","author":"C Nelke","year":"2022","unstructured":"Nelke C, Kleefeld F, Preusse C, Ruck T, Stenzel W (2022) Inclusion body myositis and associated diseases: an argument for shared immune pathologies. Acta Neuropathol Commun 10:84. https:\/\/doi.org\/10.1186\/s40478-022-01389-6","journal-title":"Acta Neuropathol Commun"},{"key":"2669_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169135","author":"C Nelke","year":"2023","unstructured":"Nelke C, Schroeter CB, Stascheit F, Huntemann N, Pawlitzki M, Willison AG et al (2023) Eculizumab treatment alters the proteometabolome beyond the inhibition of complement. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.169135","journal-title":"JCI Insight"},{"key":"2669_CR57","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jnnp-2021-328665","volume":"93","author":"C Nelke","year":"2022","unstructured":"Nelke C, Schroeter CB, Stascheit F, Pawlitzki M, Regner-Nelke L, Huntemann N et al (2022) Eculizumab versus rituximab in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry 93:548\u2013554. https:\/\/doi.org\/10.1136\/jnnp-2021-328665","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2669_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","volume":"19","author":"C Nelke","year":"2022","unstructured":"Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter CB, Huntemann N et al (2022) Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. J Neuroinflammation 19:89. https:\/\/doi.org\/10.1186\/s12974-022-02448-4","journal-title":"J Neuroinflammation"},{"key":"2669_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-020-01007-3","volume":"8","author":"M Nguyen","year":"2020","unstructured":"Nguyen M, Do V, Yell PC, Jo C, Liu J, Burns DK et al (2020) Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups. Acta Neuropathol Commun 8:125. https:\/\/doi.org\/10.1186\/s40478-020-01007-3","journal-title":"Acta Neuropathol Commun"},{"key":"2669_CR60","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","volume":"74","author":"E Noguchi","year":"2017","unstructured":"Noguchi E, Uruha A, Suzuki S, Hamanaka K, Ohnuki Y, Tsugawa J et al (2017) Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol 74:992\u2013999. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0934","journal-title":"JAMA Neurol"},{"key":"2669_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"2669_CR63","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/rheumatology\/keac526","volume":"62","author":"D Pehl","year":"2023","unstructured":"Pehl D, Preu\u00dfe C, Allenbach Y, Benveniste O, Dittert P, Alten R et al (2023) Eosinophilic fasciitis (Shulman syndrome)-recognition of the histological spectrum allows for new insights into possible pathomechanisms. Rheumatology (Oxford) 62:2005\u20132014. https:\/\/doi.org\/10.1093\/rheumatology\/keac526","journal-title":"Rheumatology (Oxford)"},{"key":"2669_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","volume":"20","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL (2018) Immune-mediated necrotizing myopathy. Curr Rheumatol Rep 20:21. https:\/\/doi.org\/10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"key":"2669_CR65","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/ard-2022-223792","volume":"82","author":"I Pinal-Fernandez","year":"2023","unstructured":"Pinal-Fernandez I, Quintana A, Milisenda JC, Casal-Dominguez M, Mu\u00f1oz-Braceras S, Derfoul A et al (2023) Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. Ann Rheum Dis 82:829\u2013836. https:\/\/doi.org\/10.1136\/ard-2022-223792","journal-title":"Ann Rheum Dis"},{"key":"2669_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12957","volume":"31","author":"C Preusse","year":"2021","unstructured":"Preusse C, Eede P, Heinzeling L, Freitag K, Koll R, Froehlich W et al (2021) Nanostring technology distinguishes anti-TIF-1\u03b3+ from anti-Mi-2+ dermatomyositis patients. Brain Pathol 31:e12957. https:\/\/doi.org\/10.1111\/bpa.12957","journal-title":"Brain Pathol"},{"key":"2669_CR67","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","volume":"181","author":"C Preu\u00dfe","year":"2012","unstructured":"Preu\u00dfe C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K et al (2012) Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am J Pathol 181:2161\u20132171. https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.033","journal-title":"Am J Pathol"},{"key":"2669_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02438-z","author":"C Preu\u00dfe","year":"2022","unstructured":"Preu\u00dfe C, Paesler B, Nelke C, Cengiz D, M\u00fcntefering T, Roos A et al (2022) Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-022-02438-z","journal-title":"Acta Neuropathol"},{"key":"2669_CR69","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","volume":"19","author":"ES Reis","year":"2019","unstructured":"Reis ES, Mastellos DC, Hajishengallis G, Lambris JD (2019) New insights into the immune functions of complement. Nat Rev Immunol 19:503\u2013516. https:\/\/doi.org\/10.1038\/s41577-019-0168-x","journal-title":"Nat Rev Immunol"},{"key":"2669_CR70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MD.0b013e31824d9cec","volume":"91","author":"A Rigolet","year":"2012","unstructured":"Rigolet A, Musset L, Dubourg O, Maisonobe T, Grenier P, Charuel J-L et al (2012) Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine (Baltimore) 91:95\u2013102. https:\/\/doi.org\/10.1097\/MD.0b013e31824d9cec","journal-title":"Medicine (Baltimore)"},{"key":"2669_CR71","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/mus.26985","volume":"62","author":"MH Rivner","year":"2020","unstructured":"Rivner MH, Quarles BM, Pan J, Yu Z, Howard JF, Corse A et al (2020) Clinical features of LRP4\/agrin-antibody-positive myasthenia gravis: a multicenter study. Muscle Nerve 62:333\u2013343. https:\/\/doi.org\/10.1002\/mus.26985","journal-title":"Muscle Nerve"},{"key":"2669_CR72","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3389\/fneur.2020.00660","volume":"11","author":"C Rodolico","year":"2020","unstructured":"Rodolico C, Bonanno C, Toscano A, Vita G (2020) MuSK-associated myasthenia gravis: clinical features and management. Front Neurol 11:660. https:\/\/doi.org\/10.3389\/fneur.2020.00660","journal-title":"Front Neurol"},{"key":"2669_CR73","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3389\/fimmu.2019.01040","volume":"10","author":"A Roos","year":"2019","unstructured":"Roos A, Preusse C, Hathazi D, Goebel H-H, Stenzel W (2019) Proteomic profiling unravels a key role of specific macrophage subtypes in sporadic inclusion body myositis. Front Immunol 10:1040","journal-title":"Front Immunol"},{"key":"2669_CR74","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","volume":"78","author":"S Rothwell","year":"2019","unstructured":"Rothwell S, Chinoy H, Lamb JA, Miller FW, Rider LG, Wedderburn LR et al (2019) Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups. Ann Rheum Dis 78:996\u20131002. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215046","journal-title":"Ann Rheum Dis"},{"key":"2669_CR75","doi-asserted-by":"publisher","first-page":"43230","DOI":"10.18632\/oncotarget.6462","volume":"6","author":"T Ruck","year":"2015","unstructured":"Ruck T, Bittner S, Afzali AM, G\u00f6bel K, Glumm S, Kraft P et al (2015) The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies. Oncotarget 6:43230\u201343243. https:\/\/doi.org\/10.18632\/oncotarget.6462","journal-title":"Oncotarget"},{"key":"2669_CR76","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1158\/2159-8290.CD-22-1180","volume":"13","author":"J-E Salem","year":"2023","unstructured":"Salem J-E, Bretagne M, Abbar B, Leonard-Louis S, Ederhy S, Redheuil A et al (2023) Abatacept\/ruxolitinib and screening for concomitant respiratory muscle failure to mitigate fatality of immune-checkpoint inhibitor myocarditis. Cancer Discov 13:1100\u20131115. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1180","journal-title":"Cancer Discov"},{"key":"2669_CR77","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1093\/rheumatology\/keac569","volume":"62","author":"T Sasai","year":"2023","unstructured":"Sasai T, Nakashima R, Shirakashi M, Hiwa R, Tsuji H, Kitagori K et al (2023) A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome. Rheumatology (Oxford) 62:e155\u2013e157. https:\/\/doi.org\/10.1093\/rheumatology\/keac569","journal-title":"Rheumatology (Oxford)"},{"key":"2669_CR78","doi-asserted-by":"publisher","first-page":"14426","DOI":"10.1038\/s41598-017-14350-8","volume":"7","author":"A Saxena","year":"2017","unstructured":"Saxena A, Stevens J, Cetin H, Koneczny I, Webster R, Lazaridis K et al (2017) Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient. Sci Rep 7:14426. https:\/\/doi.org\/10.1038\/s41598-017-14350-8","journal-title":"Sci Rep"},{"key":"2669_CR79","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ana.20341","volume":"57","author":"H Shiraishi","year":"2005","unstructured":"Shiraishi H, Motomura M, Yoshimura T, Fukudome T, Fukuda T, Nakao Y et al (2005) Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 57:289\u2013293. https:\/\/doi.org\/10.1002\/ana.20341","journal-title":"Ann Neurol"},{"key":"2669_CR80","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00401-021-02305-3","volume":"141","author":"E Siegert","year":"2021","unstructured":"Siegert E, Uruha A, Goebel H-H, Preu\u00dfe C, Casteleyn V, Kleefeld F et al (2021) Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology. Acta Neuropathol 141:917\u2013927. https:\/\/doi.org\/10.1007\/s00401-021-02305-3","journal-title":"Acta Neuropathol"},{"key":"2669_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/WNL.50.1.41","volume":"50","author":"S Spuler","year":"1998","unstructured":"Spuler S, Engel AG (1998) Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies. Neurology 50:41\u201346. https:\/\/doi.org\/10.1212\/WNL.50.1.41","journal-title":"Neurology"},{"key":"2669_CR82","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0000000000001422","volume":"84","author":"W Stenzel","year":"2015","unstructured":"Stenzel W, Preu\u00dfe C, Allenbach Y, Pehl D, Junckerstorff R, Heppner FL et al (2015) Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy. Neurology 84:1346\u20131354. https:\/\/doi.org\/10.1212\/WNL.0000000000001422","journal-title":"Neurology"},{"key":"2669_CR83","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13155","volume":"33","author":"J Tanboon","year":"2023","unstructured":"Tanboon J, Inoue M, Hirakawa S, Tachimori H, Hayashi S, Noguchi S et al (2023) Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathol 33:e13155. https:\/\/doi.org\/10.1111\/bpa.13155","journal-title":"Brain Pathol"},{"key":"2669_CR84","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","volume":"98","author":"J Tanboon","year":"2022","unstructured":"Tanboon J, Inoue M, Saito Y, Tachimori H, Hayashi S, Noguchi S et al (2022) Dermatomyositis: muscle pathology according to antibody subtypes. Neurology 98:e739\u2013e749. https:\/\/doi.org\/10.1212\/WNL.0000000000013176","journal-title":"Neurology"},{"key":"2669_CR85","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/WCO.0000000000001091","volume":"35","author":"J Tanboon","year":"2022","unstructured":"Tanboon J, Nishino I (2022) Update on dermatomyositis. Curr Opin Neurol 35:611\u2013621. https:\/\/doi.org\/10.1097\/WCO.0000000000001091","journal-title":"Curr Opin Neurol"},{"key":"2669_CR86","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12962","volume":"31","author":"J Tanboon","year":"2021","unstructured":"Tanboon J, Uruha A, Arahata Y, Dittmayer C, Schweizer L, Goebel H-H et al (2021) Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy. Brain Pathol 31:e12962. https:\/\/doi.org\/10.1111\/bpa.12962","journal-title":"Brain Pathol"},{"key":"2669_CR87","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","volume":"33","author":"J Tanboon","year":"2020","unstructured":"Tanboon J, Uruha A, Stenzel W, Nishino I (2020) Where are we moving in the classification of idiopathic inflammatory myopathies? Curr Opin Neurol 33:590\u2013603. https:\/\/doi.org\/10.1097\/WCO.0000000000000855","journal-title":"Curr Opin Neurol"},{"key":"2669_CR88","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000635","volume":"9","author":"E Tiniakou","year":"2022","unstructured":"Tiniakou E, Goldman D, Corse A, Mammen A, Petri MA (2022) Clinical and histopathological features of myositis in systemic lupus erythematosus. Lupus Sci Med 9:e000635. https:\/\/doi.org\/10.1136\/lupus-2021-000635","journal-title":"Lupus Sci Med"},{"key":"2669_CR89","first-page":"1811","volume":"30","author":"C Toquet","year":"2003","unstructured":"Toquet C, Hamidou MA, Renaudin K, Jarry A, Foulc P, Barbarot S et al (2003) In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol 30:1811\u20131815","journal-title":"J Rheumatol"},{"key":"2669_CR90","doi-asserted-by":"publisher","first-page":"e985","DOI":"10.1212\/WNL.0000000000006124","volume":"91","author":"M Touat","year":"2018","unstructured":"Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Aur\u00e9 K et al (2018) Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology 91:e985\u2013e994. https:\/\/doi.org\/10.1212\/WNL.0000000000006124","journal-title":"Neurology"},{"key":"2669_CR91","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.nmd.2019.03.002","volume":"29","author":"B Udd","year":"2019","unstructured":"Udd B, Stenzel W, Oldfors A, Oliv\u00e9 M, Romero N, Lammens M et al (2019) 1st ENMC European meeting: the EURO-NMD pathology working group recommended standards for muscle pathology Amsterdam, The Netherlands, 7 December 2018. Neuromuscul Disord 29:483\u2013485. https:\/\/doi.org\/10.1016\/j.nmd.2019.03.002","journal-title":"Neuromuscul Disord"},{"key":"2669_CR92","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/nan.12519","volume":"45","author":"A Uruha","year":"2019","unstructured":"Uruha A, Allenbach Y, Charuel J-L, Musset L, Aussy A, Boyer O et al (2019) Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis. Neuropathol Appl Neurobiol 45:513\u2013522. https:\/\/doi.org\/10.1111\/nan.12519","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2669_CR93","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","volume":"88","author":"A Uruha","year":"2017","unstructured":"Uruha A, Nishikawa A, Tsuburaya RS, Hamanaka K, Kuwana M, Watanabe Y et al (2017) Sarcoplasmic MxA expression: a valuable marker of dermatomyositis. Neurology 88:493\u2013500. https:\/\/doi.org\/10.1212\/WNL.0000000000003568","journal-title":"Neurology"},{"key":"2669_CR62","first-page":"136","volume":"75","author":"J van der Pas","year":"2004","unstructured":"van der Pas J, Hengstman GJD, ter Laak HJ, Borm GF, van Engelen BGM (2004) Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. J Neurol Neurosurg Psychiatry 75:136\u2013139","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2669_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00520","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2014.00520","journal-title":"Front Immunol"},{"key":"2669_CR95","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/WCO.0000000000000375","volume":"29","author":"J Vissing","year":"2016","unstructured":"Vissing J (2016) Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies. Curr Opin Neurol 29:635\u2013641. https:\/\/doi.org\/10.1097\/WCO.0000000000000375","journal-title":"Curr Opin Neurol"},{"key":"2669_CR96","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100066","author":"T Vu","year":"2022","unstructured":"Vu T, Meisel A, Mantegazza R, Annane D, Katsuno M, Aguzzi R et al (2022) Terminal complement inhibitor ravulizumab in generalized myasthenia gravis. NEJM Evid. https:\/\/doi.org\/10.1056\/EVIDoa2100066","journal-title":"NEJM Evid"},{"key":"2669_CR97","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/ard-2022-222686","volume":"82","author":"J-B Vulsteke","year":"2022","unstructured":"Vulsteke J-B, Derua R, Dubucquoi S, Coutant F, Sanges S, Goncalves D et al (2022) Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies. Ann Rheum Dis 82:546\u2013555. https:\/\/doi.org\/10.1136\/ard-2022-222686","journal-title":"Ann Rheum Dis"},{"key":"2669_CR98","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K et al (2016) Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 87:1038\u20131044. https:\/\/doi.org\/10.1136\/jnnp-2016-313166","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2669_CR99","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.150019","volume":"5","author":"AJM Wollman","year":"2015","unstructured":"Wollman AJM, Nudd R, Hedlund EG, Leake MC (2015) From animaculum to single molecules: 300 years of the light microscope. Open Biol 5:150019. https:\/\/doi.org\/10.1098\/rsob.150019","journal-title":"Open Biol"},{"key":"2669_CR100","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12891-022-05372-z","volume":"23","author":"H Yang","year":"2022","unstructured":"Yang H, Tian X, Zhang L, Li W, Liu Q, Jiang W et al (2022) Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort. BMC Musculoskelet Disord 23:425. https:\/\/doi.org\/10.1186\/s12891-022-05372-z","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-023-02669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-023-02669-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-023-02669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:04:07Z","timestamp":1705017847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-023-02669-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2669"],"URL":"https:\/\/doi.org\/10.1007\/s00401-023-02669-8","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"29 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}